Pricing Log in Create free account

Cocrystal Pharma, Inc. (COCP) vs Jasper Therapeutics, Inc. (JSPR)

Cocrystal Pharma, Inc. and Jasper Therapeutics, Inc. are both Biotechnology companies. Cocrystal Pharma, Inc. is the larger, with a market value of $19.8M against $17.7M — 1.1× the size. Jasper Therapeutics, Inc. has the higher net margin (0.00% vs −747.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Jasper Therapeutics, Inc. leads on 8 and Cocrystal Pharma, Inc. on 4.

Valuation

Metric COCP JSPR Biotechnology median
P/E n/m n/m 8.50
P/S 10.58 n/m 9.71
P/B 13.47 9.75 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 8.90 n/m 9.21
Earnings yield (74.51%) (331.25%) (33.15%)
Free cash flow yield (56.64%) (437.42%) (25.50%)

Profitability

Metric COCP JSPR Biotechnology median
Gross margin 9.10% 0.00% 65.16%
Operating margin (760.72%) 0.00% 0.00%
Net margin (747.78%) 0.00% 0.00%
Free cash flow margin (598.50%) 0.00% 0.00%
Return on equity (311.68%) (255.05%) (56.36%)
Return on assets (151.10%) (109.05%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric COCP JSPR Biotechnology median
Revenue growth (TTM) (30.38%) — 6.02%
EPS growth (last fiscal year) 54.65% 19.22% 30.26%
Revenue growth, 5-year CAGR (33.30%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COCP JSPR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.24 1.48 4.72
Net debt to EBITDA 0.82 0.35 0.96

Dividend

Metric COCP JSPR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric COCP JSPR Biotechnology median
Market cap 19.84m 17.70m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack